Home4582 • TYO
add
Symbio Pharmaceuticals Ltd
Previous close
¥160.00
Day range
¥145.00 - ¥207.00
Year range
¥81.00 - ¥220.00
Market cap
13.57B JPY
Avg Volume
7.20M
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
Financials
Income Statement
Revenue
Net income
| (JPY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 336.84M | -39.16% |
Operating expense | 1.35B | -10.66% |
Net income | -1.21B | -22.53% |
Net profit margin | -359.38 | -101.39% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -1.63% | — |
Balance Sheet
Total assets
Total liabilities
| (JPY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.88B | -27.24% |
Total assets | 3.87B | -22.16% |
Total liabilities | 2.60B | 235.74% |
Total equity | 1.27B | — |
Shares outstanding | 59.48M | — |
Price to book | 7.48 | — |
Return on assets | -65.18% | — |
Return on capital | -75.98% | — |
Cash Flow
Net change in cash
| (JPY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.21B | -22.53% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Mar 25, 2005
Headquarters
Website
Employees
108
